Eric Haueter is a corporate partner in the San Francisco office. His principal areas of practice include capital markets, securities, mergers and acquisitions and general corporate matters.
Mr. Haueter has represented underwriters and companies in a broad range of public and private debt and equity financings, merger and acquisition transactions and other matters.
Selected representative transactions in which Mr. Haueter has participated include IPOs for companies such as Arbor Realty, Carrols Restaurant Group, Dolby Laboratories, IPC—The Hospitalist Company, KKR Financial, Morton’s Restaurant Group, NUCRYST Pharmaceuticals, Zogenix and Zumiez; offerings of convertible debt and other equity-linked securities for issuers such as Edwards Lifesciences, Finisar, Kilroy Realty, Placer Dome, Wells Fargo and Weyerhaeuser; PIPEs and registered directs for issuers such as Capstone Turbine, ISTA Pharmaceuticals and MannKind; add-on common stock offerings for issuers such as Actuant, Nektar Therapeutics, O’Charley’s, Performance Foods, SI International, Tuesday Morning and Weyerhaeuser; debt and equity offerings for REITs such as Equity Office Properties, Federal Realty, HCP, Kilroy Realty, Mid-America Apartment Communities, QTS Realty, Realty Income Corporation and United Dominion.
Mr. Haueter is admitted to practice in California and New York.